Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liver cancer
Pharma
BMS shoots for 1L liver cancer again with Opdivo, Yervoy combo
If approved by the FDA, BMS' Opdivo-Yervoy combo will go toe to toe with Roche's and AstraZeneca's immunotherapies in first-line liver cancer.
Angus Liu
Mar 20, 2024 10:18am
Blue Faery to boost liver cancer awareness
Feb 5, 2024 8:52am
AZ charts new but uncertain path for Imfinzi in liver cancer
Jan 19, 2024 10:00am
Hengrui, Elevar strike $600M marketing deal for liver cancer med
Oct 17, 2023 11:47am
Eisai, Astellas, GSK and more—Fierce Pharma Asia
Jul 21, 2023 8:15am
UK's NICE signs off on Gilead's hepatitis D drug
May 15, 2023 10:15am